Literature DB >> 11253605

Central nervous system involvement in adult acute lymphocytic leukemia.

J Cortes1.   

Abstract

With effective CNS prophylaxis, most adults with ALL may remain free of CNS leukemia. Several combinations of IT chemotherapy, high-dose systemic chemotherapy, and cranial irradiation have been used with varying results. Excellent prophylaxis can be achieved without cranial irradiation, and in view of the potential acute and long-term toxicity of radiation, these methods may be preferable. A prophylactic approach tailored to the risk of CNS leukemia was shown to be valuable in childhood ALL and in at least one adult study. Further studies should focus on defining risk groups for CNS leukemia and designing effective prophylaxis for each group. More research is needed to define the intensity and duration of treatment and the role of cranial irradiation in the treatment of isolated CNS relapses.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11253605     DOI: 10.1016/s0889-8588(05)70203-3

Source DB:  PubMed          Journal:  Hematol Oncol Clin North Am        ISSN: 0889-8588            Impact factor:   3.722


  18 in total

Review 1.  Leukemia and the nervous system.

Authors:  Marc C Chamberlain
Journal:  Curr Oncol Rep       Date:  2005-01       Impact factor: 5.075

2.  VE-cadherin and PECAM-1 enhance ALL migration across brain microvascular endothelial cell monolayers.

Authors:  Stephen M Akers; Heather A O'Leary; Fred L Minnear; Michael D Craig; Jeffrey A Vos; James E Coad; Laura F Gibson
Journal:  Exp Hematol       Date:  2010-05-12       Impact factor: 3.084

3.  Cellular elements of the subarachnoid space promote ALL survival during chemotherapy.

Authors:  Stephen M Akers; Stephanie L Rellick; James E Fortney; Laura F Gibson
Journal:  Leuk Res       Date:  2011-01-26       Impact factor: 3.156

4.  Anaplastic oligoastrocytoma: previous treatment as a possible cause in a child with acute lymphoblastic leukemia.

Authors:  Necmettin Tanriover; Mustafa Onur Ulu; Mehmet Sar; Mustafa Uzan
Journal:  Childs Nerv Syst       Date:  2006-10-17       Impact factor: 1.475

5.  The overwhelmingly positive response to Dasatinib of a patient with multiple blast crisis of chronic myeloid leukemia.

Authors:  Zhengli Xu; Miao Zheng; Chaonan Wu; Yujia Ma; Li Meng; Jianfeng Zhou; Ying Wang
Journal:  Int J Clin Exp Med       Date:  2015-01-15

Review 6.  Leukemic and lymphomatous meningitis: incidence, prognosis and treatment.

Authors:  Marc C Chamberlain; Craig Nolan; Lauren E Abrey
Journal:  J Neurooncol       Date:  2005-10       Impact factor: 4.130

7.  Retrovirus-transformed erythroleukemia cells induce central nervous system failure in a new syngeneic mouse model of meningeal leukemia.

Authors:  Gordon R Macpherson; Charlotte A Hanson; Delores M Thompson; Christine M Perella; Joan L Cmarik; Sandra K Ruscetti
Journal:  Leuk Res       Date:  2011-09-15       Impact factor: 3.156

Review 8.  Central Nervous System Involvement in Adults with Acute Leukemia: Diagnosis, Prevention, and Management.

Authors:  Shilpa Paul; Nicholas J Short
Journal:  Curr Oncol Rep       Date:  2022-02-10       Impact factor: 5.075

Review 9.  Philadelphia chromosome-positive acute lymphoblastic leukemia.

Authors:  Farhad Ravandi; Partow Kebriaei
Journal:  Hematol Oncol Clin North Am       Date:  2009-10       Impact factor: 3.722

Review 10.  Central nervous system niche involvement in the leukemia.

Authors:  N Heidari; N Saki; L De Filippis; M Shahjahani; A Teimouri; A Ahmadzadeh
Journal:  Clin Transl Oncol       Date:  2015-08-05       Impact factor: 3.405

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.